CIK 0001817229
VOR Vor Biopharma Inc.
Insider trading from SEC Form 4. Last filing Feb 7, 2025.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
5
with a Form 4 at this company
Signals
Open-market buys and sells at Vor Biopharma Inc., scored.
| Score | Side | Insider | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 0Weak | sell10b5-1 | Attar Eyal C. CHIEF MEDICAL OFFICER | $13k | 10,334 | -11% | - |
Transactions
The last 29 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 6, 2025 | ANG ROBERT PRESIDENT AND CEO | FTax withholding Common Stock | -2,787 | $1.50 | $4,181 | 918,952 | Feb 7, 2025 |
| Feb 3, 2025 | ANG ROBERT PRESIDENT AND CEO | FTax withholding Common Stock | -3,248 | $1.34 | $4,352 | 784,239 | Feb 5, 2025 |
| Feb 3, 2025 | ANG ROBERT PRESIDENT AND CEO | AGrant or award Common Stock | +137,500 | $0.00 | $0 | 921,739 | Feb 5, 2025 |
| Feb 3, 2025 | ANG ROBERT PRESIDENT AND CEO | DDisposition to issuer Employee Stock Option (right to buy)derivative | -147,294 | $0.00 | $0 | 0 | Feb 5, 2025 |
| Feb 3, 2025 | ANG ROBERT PRESIDENT AND CEO | AGrant or award Employee Stock Option (right to buy)derivative | +147,294 | $0.00 | $0 | 147,294 | Feb 5, 2025 |
| Feb 3, 2025 | ANG ROBERT PRESIDENT AND CEO | DDisposition to issuer Employee Stock Option (right to buy)derivative | -652,086 | $0.00 | $0 | 0 | Feb 5, 2025 |
| Feb 3, 2025 | ANG ROBERT PRESIDENT AND CEO | AGrant or award Employee Stock Option (right to buy)derivative | +652,086 | $0.00 | $0 | 652,086 | Feb 5, 2025 |
| Feb 3, 2025 | ANG ROBERT PRESIDENT AND CEO | DDisposition to issuer Employee Stock Option (right to buy)derivative | -51,060 | $0.00 | $0 | 0 | Feb 5, 2025 |
| Feb 3, 2025 | ANG ROBERT PRESIDENT AND CEO | AGrant or award Employee Stock Option (right to buy)derivative | +51,060 | $0.00 | $0 | 51,060 | Feb 5, 2025 |
| Feb 3, 2025 | ANG ROBERT PRESIDENT AND CEO | DDisposition to issuer Employee Stock Option (right to buy)derivative | -376,000 | $0.00 | $0 | 0 | Feb 5, 2025 |
| Feb 3, 2025 | ANG ROBERT PRESIDENT AND CEO | AGrant or award Employee Stock Option (right to buy)derivative | +376,000 | $0.00 | $0 | 376,000 | Feb 5, 2025 |
| Feb 3, 2025 | ANG ROBERT PRESIDENT AND CEO | DDisposition to issuer Employee Stock Option (right to buy)derivative | -172,500 | $0.00 | $0 | 0 | Feb 5, 2025 |
| Feb 3, 2025 | ANG ROBERT PRESIDENT AND CEO | AGrant or award Employee Stock Option (right to buy)derivative | +172,500 | $0.00 | $0 | 172,500 | Feb 5, 2025 |
| Feb 3, 2025 | ANG ROBERT PRESIDENT AND CEO | DDisposition to issuer Employee Stock Option (right to buy)derivative | -257,500 | $0.00 | $0 | 0 | Feb 5, 2025 |
| Feb 3, 2025 | ANG ROBERT PRESIDENT AND CEO | AGrant or award Employee Stock Option (right to buy)derivative | +257,500 | $0.00 | $0 | 257,500 | Feb 5, 2025 |
| Feb 3, 2025 | ANG ROBERT PRESIDENT AND CEO | DDisposition to issuer Employee Stock Option (right to buy)derivative | -470,000 | $0.00 | $0 | 0 | Feb 5, 2025 |
| Feb 3, 2025 | ANG ROBERT PRESIDENT AND CEO | AGrant or award Employee Stock Option (right to buy)derivative | +470,000 | $0.00 | $0 | 470,000 | Feb 5, 2025 |
| Feb 3, 2025 | ANG ROBERT PRESIDENT AND CEO | AGrant or award Employee Stock Option (right to buy)derivative | +825,000 | $0.00 | $0 | 825,000 | Feb 5, 2025 |
| Dec 27, 2024 | Attar Eyal C. CHIEF MEDICAL OFFICER | SOpen-market sale Common Stock10b5-1 | -10,334 | $1.25 | $13k | 81,439 | Dec 31, 2024 |
| Dec 30, 2024 | RA CAPITAL MANAGEMENT, L.P. director, owner | AGrant or award Common Stockindirect: See footnotes | +16,897,159 | - | - | 37,820,713 | Dec 30, 2024 |
| Dec 30, 2024 | RA CAPITAL MANAGEMENT, L.P. director, owner | AGrant or award Warrant (Right to Buy)derivativeindirect: See Footnotes | +21,121,449 | - | - | 21,121,449 | Dec 30, 2024 |
| Nov 6, 2024 | ANG ROBERT PRESIDENT AND CEO | FTax withholding Common Stock | -2,361 | $0.86 | $2,030 | 787,487 | Nov 8, 2024 |
| Nov 6, 2024 | Attar Eyal C. CHIEF MEDICAL OFFICER | FTax withholding Common Stock | -999 | $0.86 | $859 | 91,773 | Nov 8, 2024 |
| Nov 6, 2024 | Chakraborty Tirtha CHIEF SCIENTIFIC OFFICER | FTax withholding Common Stock | -875 | $0.86 | $753 | 169,935 | Nov 8, 2024 |
| Nov 6, 2024 | Quinlan Amy Vice President of Finance | FTax withholding Common Stock | -206 | $0.86 | $177 | 50,312 | Nov 8, 2024 |
| Nov 1, 2024 | ANG ROBERT PRESIDENT AND CEO | FTax withholding Common Stock | -2,751 | $0.80 | $2,201 | 789,848 | Nov 5, 2024 |
| Nov 1, 2024 | Attar Eyal C. CHIEF MEDICAL OFFICER | FTax withholding Common Stock | -1,146 | $0.80 | $917 | 92,772 | Nov 5, 2024 |
| Nov 1, 2024 | Chakraborty Tirtha CHIEF SCIENTIFIC OFFICER | FTax withholding Common Stock | -986 | $0.80 | $789 | 170,810 | Nov 5, 2024 |
| Nov 1, 2024 | Quinlan Amy Vice President of Finance | FTax withholding Common Stock | -343 | $0.80 | $274 | 50,518 | Nov 5, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- ANG ROBERTPRESIDENT AND CEO
- Attar Eyal C.CHIEF MEDICAL OFFICER
- Chakraborty TirthaCHIEF SCIENTIFIC OFFICER
- Quinlan AmyVice President of Finance
- RA CAPITAL MANAGEMENT, L.P.owner, director
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.